Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business – Read more

WATCH RECORDINGS NOW!
ESMO 2023 Industry Satellite Symposium

Accessing cutting-edge precision oncology through local testing

Watch the ESMO Satellite Symposium Recordings to continue the conversation around utilizing genomic testing for enhanced treatment decisions. Chaired by Prof. Pascal Pujol and Prof. Carsten Denkert, watching the recordings of the symposium you will be able to:

  • Dive into the world of prospective real-world data, confirming the predictive and prognostic power of EndoPredict
  • Engage in a thought-provoking dialogue on the interchangeability of HRD tests
  • Gain exclusive insights into the implementation of local LoE1A HRD testing for ovarian cancer patients within a center of excellence
HRD Implementation HRD Round Table EndoPredict Presentation

 

ESMO 2023 Satellite Symposium – HRD Presentation

How to implement local LoE1A HRD testing: experience of a center of excellence

Prof. Denkert

ESMO 2023 Satellite Symposium – HRD Round Table

Optimal HRD ovarian cancer treatment –
Are genomic tests interchangeable?

Prof. Pujol, Prof. Denkert, Prof. You, Prof. Marmé

 

 

ESMO 2023 Satellite Symposium – Breast Cancer Test Presentation

Real world prospective data support prognostic and predictive second-generation breast cancer signature performance

Dr. Klein

Our panel of speakers

Prof. Pascal
Pujol

University Hospital Center
Cancer and Genetics
Montpellier, France

Prof. Carsten
Denkert

University Hospital
Pathology
Marburg, Germany

Prof. Benoît
You

Lyon-Sud Hospital
Medical Oncology
Lyon, France

Prof. Frederik
Marmé

University Medical Center
Gynecology
Mannheim, Germany

Dr. Evelyn
Klein

Technical University of Munich
Interdisciplinary Breast Center
Munich, Germany

Full Program

Accessing cutting-edge precision oncology
through local testing

Chairs: Prof. Pascal Pujol & Prof. Carsten Denkert

Time Agenda Speakers
Ovarian Cancer
13:00 Introduction to the HRD round table Prof. Pascal Pujol
13:05 Optimal HRD ovarian cancer treatment – Are genomic tests interchangeable? Prof. Carsten Denkert, Prof. Benoît You, Prof. Frederik Marmé
13:25 How to implement local LoE1A HRD testing: experience of a center of excellence Prof. Carsten Denkert
13:40 Live Q&A
Breast Cancer
13:50 Real world prospective data support prognostic and predictive second-generation breast cancer signature performance Dr. Evelyn Klein
14:10 Live Q&A
14:20 Conclusion Prof. Carsten Denkert
14:30 End of Symposium

Locations

United States
Europe
Japan